Success Story: Straightforward NIW Win: A Chinese Research Fellow in Biochemistry Approved Without RFE

Posted by wegreened on July 3, 2025 in NIW, Chemistry (Organic Chemistry, Biochemistry, Biochemical Engineering, Electrochemical Engineering, Physical Chemistry, Macromolecular Engineering, Polymer Chemistry, Chemical Engineering)

Client’s Testimonial:

“My EB-2 NIW case preparation took around 3–4 months, mainly due to the time needed to contact recommenders. The team provided solid guidance, clear instructions, and consistently prompt responses. I appreciated their structured process and overall support. They’ve done a great job so far. I’ve also just submitted my EB-1B case with them and hope for good news soon. I would highly recommend their services to anyone pursuing the EB-2 NIW or EB-1 route.”

On April 30^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Research Fellow

Country of Origin: China

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: April 30^th, 2025

Processing Time: 10 months, 20 days

Case Summary:

We’re proud to share the successful I-140 NIW approval of a dedicated expert from China, whose innovative work in biochemistry and cancer-neuron biology is helping pave the way for new treatments to alleviate the painful side effects of cancer therapy.

Currently conducting research in the United States, the client’s proposed endeavor focuses on investigating axon degeneration, with a particular emphasis on the SARM1 signaling pathway, a central driver of nerve damage in patients undergoing chemotherapy. Her goal is to develop therapeutic tools to mitigate chemotherapy-induced peripheral neuropathy (CIPN), a major complication that affects the quality of life for cancer patients.

To support her petition under the National Interest Waiver (NIW) category, we highlighted:

6 peer-reviewed journal articles and 1 preprint, including papers published in top-tier journals such as Science and Biosensors and Bioelectronics;
78 citations, with 3 papers ranking among the top 10–20% most cited in biology and biochemistry for their publication years;
Peer review service for scientific journals and a research role supported by major national and international funding bodies.

Her work has been widely cited by fellow researchers and has already contributed to fields including DNA biosensing, lipid kinase assay development, and neurobiology. These contributions have shaped international studies and helped advance critical discoveries related to cancer therapy and neurological protection.

With a demonstrated record of impactful publications, active collaboration in high-level research, and a clear vision for addressing a significant national health issue, our client was found to be exceptionally well-positioned to lead this work. Her petition was approved without delay.

We celebrate her success and look forward to her continued contributions to public health and biomedical innovation.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%